When decisions matter Myriad® delivers the greatest value to you and your patients through accuracy, service, and affordable testing. Myriad’s rigorous lab accuracy empowers you to make confident informed decisions
riskScore is a breast cancer risk prediction result that provides women, who are unaffected by breast cancer, with a personalized calculation of their future breast cancer risk. riskScore results uses a combination of genetic markers and clinical factors in it's calculation.
Tyrer-Cuzick is a breast cancer risk model used to predict a woman's risk of developing breast cancer. The Tyrer-Cuzick model takes into consideration family history of cancer and other personal clinical risk factors.
If your remaining lifetime breast cancer risk is calculated to be 20% or greater with Tyrer-Cuzick or riskScore, a summary of medical management guidelines will be provided.
Partner myRisk testing with riskScore™
Myriad has developed and validated riskScore, a breast cancer prediction model that calculates 5-year and remaining lifetime risk of breast cancer. myRisk is enhanced with riskScore and the results will include the multi-gene hereditary cancer panel, a clinical and cancer history analysis and riskScore which is calculated using clinical risk factors and multiple genetic markers.
Partnering Myriad myRisk® with riskScore will help manage your patient’s personalized risk with the myRisk Medical Management Tool.
The myRisk Medical Management Tool provides a summary of recent management recommendations from leading medical societies that you and your patients may consider. In general, changes to a patient’s management can take four possible directions:
myRisk is easy to order